Calumet Analyst Price Targets - Benzinga

Calumet Inc

CLMTNASDAQ

Trade with Public

Trade with Public

$49.65

1.132.32%

마지막 업데이트: Oct 30, 5:30 PM

개요 뉴스 실적 전망 이벤트목표가재무 심리 지분 현황 배당금 비교 옵션 주식 보고서

© 2026 Benzinga | All Rights Reserved

Calumet Analyst Price Targets

Wall Street analyst price targets and consensus rating for Calumet (CLMT).

Price Target Range — 11 Quarters

Analyst Consensus — 6 Analysts

3Buy

3Hold

Consensus RatingNeutral# Analysts6Avg. Consensus PT$41Upside to Avg. PT-19.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 2, 2026	HC Wainwright & Co.	Amit Dayal	PT Raise	Buy	$60→$75
Aug 25, 2026	UBS	Manav Gupta	PT Raise	Neutral	$26→$47
Aug 18, 2026	Goldman Sachs	Neil Mehta	PT Raise	Neutral	$40→$45
Aug 12, 2026	TD Cowen	Jason Gabelman	PT Raise	Hold	$34→$40
Jul 30, 2026	Goldman Sachs	Neil Mehta	PT Raise	Neutral	$36→$40
Mar 30, 2026	HC Wainwright & Co.	Amit Dayal	PT Raise	Buy	$33→$60
Mar 12, 2026	Goldman Sachs	Neil Mehta	PT Raise	Buy	$24→$34
Jan 30, 2026	Goldman Sachs	Neil Mehta	PT Raise	Buy	$20→$24
Nov 10, 2025	HC Wainwright & Co.	Amit Dayal	Maintained	Buy	$33
Oct 22, 2025	Goldman Sachs	Neil Mehta	PT Raise	Buy	$15→$20
Aug 12, 2025	UBS	Manav Gupta	PT Raise	Neutral	$12→$13
May 14, 2025	Wells Fargo	Roger Read	PT Cut	Overweight	$23→$21
May 13, 2025	B of A Securities	Conor Fitzpatrick	Initiate	Buy	$15
Apr 30, 2025	Goldman Sachs	Neil Mehta	PT Cut	Buy	$16→$14
Apr 9, 2025	Wells Fargo	Roger Read	PT Cut	Overweight	$28→$23
Mar 17, 2025	UBS	Manav Gupta	Upgrade	Sell→Neutral	$15→$12
Mar 5, 2025	Wells Fargo	Roger Read	PT Cut	Overweight	$29→$28
Mar 3, 2025	HC Wainwright & Co.	Amit Dayal	Maintained	Buy	$33
Feb 12, 2025	HC Wainwright & Co.	Amit Dayal	Maintained	Buy	$33
Feb 4, 2025	UBS	Manav Gupta	Downgrade	Neutral→Sell	$21→$15

Analyst Ratings News

Salesforce To Rally More Than 16%? Here Are 10 Top Analyst Forecasts For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Cantor Fitzgerald raised

Avi Kapoor

PRO
HC Wainwright & Co. Maintains Buy on Calumet, Raises Price Target to $75

HC Wainwright & Co. analyst Amit Dayal maintains Calumet (NASDAQ:CLMT) with a Buy and raises the price target from $60 to $75.

Benzinga Newsdesk

PRO
UBS Maintains Neutral on Calumet, Raises Price Target to $47

UBS analyst Manav Gupta maintains Calumet (NASDAQ:CLMT) with a Neutral and raises the price target from $26 to $47.

Benzinga Newsdesk

PRO
Goldman Sachs Maintains Neutral on Calumet, Raises Price Target to $45

Goldman Sachs analyst Neil Mehta maintains Calumet (NASDAQ:CLMT) with a Neutral and raises the price target from $40 to $45.

Benzinga Newsdesk

PRO
TD Cowen Maintains Hold on Calumet, Raises Price Target to $40

TD Cowen analyst Jason Gabelman maintains Calumet (NASDAQ:CLMT) with a Hold and raises the price target from $34 to $40.

Benzinga Newsdesk

PRO
Goldman Sachs Maintains Neutral on Calumet, Raises Price Target to $40

Goldman Sachs analyst Neil Mehta maintains Calumet (NASDAQ:CLMT) with a Neutral and raises the price target from $36 to $40.

Benzinga Newsdesk